250 related articles for article (PubMed ID: 20967040)
1. [Overactive pelvic floor syndrome].
Rognlid M; Lindsetmo RO
Tidsskr Nor Laegeforen; 2010 Oct; 130(20):2016-20. PubMed ID: 20967040
[TBL] [Abstract][Full Text] [Related]
2. Using botulinum toxin for pelvic indications in women.
Rao A; Abbott J
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):352-7. PubMed ID: 19694687
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles.
Jarvis SK; Abbott JA; Lenart MB; Steensma A; Vancaillie TG
Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):46-50. PubMed ID: 15089868
[TBL] [Abstract][Full Text] [Related]
4. Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain.
Abbott J
Toxicon; 2009 Oct; 54(5):647-53. PubMed ID: 19264089
[TBL] [Abstract][Full Text] [Related]
5. The use of botulinum toxin in the pelvic floor for women with chronic pelvic pain-a new answer to old problems?
Abbott J
J Minim Invasive Gynecol; 2009; 16(2):130-5. PubMed ID: 19167273
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
[TBL] [Abstract][Full Text] [Related]
7. Recognizing and treating pelvic pain and pelvic floor dysfunction.
Prather H; Spitznagle TM; Dugan SA
Phys Med Rehabil Clin N Am; 2007 Aug; 18(3):477-96, ix. PubMed ID: 17678763
[TBL] [Abstract][Full Text] [Related]
8. Pelvic floor hypertonic disorders: identification and management.
Butrick CW
Obstet Gynecol Clin North Am; 2009 Sep; 36(3):707-22. PubMed ID: 19932423
[TBL] [Abstract][Full Text] [Related]
9. The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles.
Thomson AJ; Jarvis SK; Lenart M; Abbott JA; Vancaillie TG
BJOG; 2005 Feb; 112(2):247-9. PubMed ID: 15663593
[No Abstract] [Full Text] [Related]
10. Changing treatments for overactive bladder.
Waine E; Stott M
Nurs Times; 2008 Oct 14-20; 104(41):45-8. PubMed ID: 18979960
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
[TBL] [Abstract][Full Text] [Related]
12. Behavioral treatment of urinary incontinence, voiding dysfunction, and overactive bladder.
Burgio KL
Obstet Gynecol Clin North Am; 2009 Sep; 36(3):475-91. PubMed ID: 19932411
[TBL] [Abstract][Full Text] [Related]
13. Posterior pelvic floor compartment disorders.
Davis K; Kumar D
Best Pract Res Clin Obstet Gynaecol; 2005 Dec; 19(6):941-58. PubMed ID: 16198148
[TBL] [Abstract][Full Text] [Related]
14. The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study.
Mehnert U; Birzele J; Reuter K; Schurch B
J Urol; 2010 Sep; 184(3):1011-6. PubMed ID: 20643431
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and pathophysiology of pelvic pain in women].
Wesselmann U
Schmerz; 2002 Dec; 16(6):467-75. PubMed ID: 12474033
[TBL] [Abstract][Full Text] [Related]
16. Overactive bladder syndrome - management and treatment options.
Arnold J; McLeod N; Thani-Gasalam R; Rashid P
Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
[TBL] [Abstract][Full Text] [Related]
17. The effects of pelvic floor muscle therapy on symptoms, voiding, and pelvic floor muscle activity parameters in children with overactive bladder.
Pekbay Y; Ergin O; Topuz B; Sarikaya S; Acar ZZ; Irkilata HC; Dayanç M
Neurourol Urodyn; 2019 Jun; 38(5):1430-1442. PubMed ID: 31006136
[TBL] [Abstract][Full Text] [Related]
18. One-year follow-up study on the effects of electrogalvanic stimulation in chronic idiopathic constipation with pelvic floor dyssynergia.
Chiarioni G; Chistolini F; Menegotti M; Salandini L; Vantini I; Morelli A; Bassotti G
Dis Colon Rectum; 2004 Mar; 47(3):346-53. PubMed ID: 14991497
[TBL] [Abstract][Full Text] [Related]
19. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome.
Suttor VP; Prott GM; Hansen RD; Kellow JE; Malcolm A
Dis Colon Rectum; 2010 Feb; 53(2):156-60. PubMed ID: 20087090
[TBL] [Abstract][Full Text] [Related]
20. Effects of magnetic stimulation in the treatment of pelvic floor dysfunction.
Voorham-van der Zalm PJ; Pelger RC; Stiggelbout AM; Elzevier HW; Lycklama à Nijeholt GA
BJU Int; 2006 May; 97(5):1035-8. PubMed ID: 16643487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
